Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.

Singh N, Gayowski T, Yu VL, Wagener MM.

Ann Intern Med. 1995 Apr 15;122(8):595-8.

PMID:
7887554
2.

Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.

Alvarez RF, Mattos AA, Corrêa EB, Cotrim HP, Nascimento TV.

Arq Gastroenterol. 2005 Oct-Dec;42(4):256-62. Epub 2006 Jan 19.

3.
4.

Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.

Lontos S, Gow PJ, Vaughan RB, Angus PW.

J Gastroenterol Hepatol. 2008 Feb;23(2):252-5. Epub 2007 Jun 7.

PMID:
17559367
5.

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.

Hepatology. 1997 Mar;25(3):532-6.

PMID:
9049193
6.

Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis.

Inadomi J, Sonnenberg A.

Gastroenterology. 1997 Oct;113(4):1289-94.

PMID:
9322524
7.

Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.

Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.

J Gastroenterol Hepatol. 2005 Apr;20(4):599-605.

PMID:
15836710
8.

A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.

Lontos S, Shelton E, Angus PW, Vaughan R, Roberts SK, Gordon A, Gow PJ.

J Dig Dis. 2014 May;15(5):260-7. doi: 10.1111/1751-2980.12132.

PMID:
24612987
9.

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M.

Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285.

PMID:
17030175
10.

Trimethoprim--sulfamethoxazole prophylaxis of spontaneous bacterial peritonitis.

Nishioka SD.

Ann Intern Med. 1995 Nov 15;123(10):810. No abstract available.

PMID:
7574208
11.

Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels.

Guarner C, Solà R, Soriano G, Andreu M, Novella MT, Vila MC, Sàbat M, Coll S, Ortiz J, Gómez C, Balanzó J.

Gastroenterology. 1999 Aug;117(2):414-9.

PMID:
10419924
12.

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.

Fernández J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V, Such J, Ginès P, Arroyo V.

Gastroenterology. 2007 Sep;133(3):818-24. Epub 2007 Jul 3.

PMID:
17854593
14.

Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.

Frazee LA, Marinos AE, Rybarczyk AM, Fulton SA.

Ann Pharmacother. 2005 May;39(5):908-12. Epub 2005 Mar 15. Review.

PMID:
15769829
15.

Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.

Kaymakoglu S, Eraksoy H, Okten A, Demir K, Calangu S, Cakaloglu Y, Boztas G, Besisik F.

Eur J Gastroenterol Hepatol. 1997 Jan;9(1):71-6.

PMID:
9031903
16.

Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration.

Llach J, Rimola A, Navasa M, Ginès P, Salmerón JM, Ginès A, Arroyo V, Rodés J.

Hepatology. 1992 Sep;16(3):724-7.

PMID:
1505916
18.

Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial?

Cholongitas E, Papatheodoridis GV, Manesis EK, Burroughs AK, Archimandritis AJ.

J Gastroenterol Hepatol. 2006 Mar;21(3):581-7.

PMID:
16638103

Supplemental Content

Support Center